Invention Grant
- Patent Title: Systems and methods for artificial intelligence-based image analysis for cancer assessment
-
Application No.: US16734609Application Date: 2020-01-06
-
Publication No.: US11564621B2Publication Date: 2023-01-31
- Inventor: Aseem Undvall Anand , Karl Vilhelm Sjöstrand , Jens Filip Andreas Richter
- Applicant: Progenics Pharmaceuticals, Inc. , EXINI Diagnostics AB
- Applicant Address: US MA N. Billerica; SE Lund
- Assignee: Progenics Pharmaceuticals, Inc.,EXINI Diagnostics AB
- Current Assignee: Progenics Pharmaceuticals, Inc.,EXINI Diagnostics AB
- Current Assignee Address: US MA N. Billerica; SE Lund
- Agency: Choate, Hall & Stewart LLP
- Agent William R. Haulbrook; Ronen Adato
- Main IPC: G06T7/00
- IPC: G06T7/00 ; A61B5/00 ; G16H50/30 ; G06N3/08 ; G06N20/00

Abstract:
Presented herein are systems and methods that provide for automated analysis of medical images to determine a predicted disease status (e.g., prostate cancer status) and/or a value corresponding to predicted risk of the disease status for a subject. The approaches described herein leverage artificial intelligence (AI) to analyze intensities of voxels in a functional image, such as a PET image, and determine a risk and/or likelihood that a subject's disease, e.g., cancer, is aggressive. The approaches described herein can provide predictions of whether a subject that presents a localized disease has and/or will develop aggressive disease, such as metastatic cancer. These predictions are generated in a fully automated fashion and can be used alone, or in combination with other cancer diagnostic metrics (e.g., to corroborate predictions and assessments or highlight potential errors). As such, they represent a valuable tool in support of improved cancer diagnosis and treatment.
Public/Granted literature
- US20210093249A1 SYSTEMS AND METHODS FOR ARTIFICIAL INTELLIGENCE-BASED IMAGE ANALYSIS FOR CANCER ASSESSMENT Public/Granted day:2021-04-01
Information query